Airways diseases II

I. Horvath (Budapest, Hungary)

Source: ERS Course 2015
Number: 13
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Horvath (Budapest, Hungary). Airways diseases II. ERS Course 2015

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Airways diseases I
Source: ERS Course 2015
Year: 2015

Airways diseases I
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Airways disease
Source: Virtual Congress 2020 – Impact in children and in adults with premorbid respiratory disease (acute and long-term)
Year: 2020


Airways infections in patients with interstitial lung diseases
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009


Inflammatory airway diseases and clinical allergy: Inflammatory Airways Diseases and Clinical Allergy Assembly contribution to the celebration of 20 years of the ERS
Source: Eur Respir J 2010; 35: 1197-1199
Year: 2010


Late Breaking Abstract - Small Airways Dysfunction (SAD) correlates with relevant asthma outcomes: longitudinal results from the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Airways renin angiotensin system activation during allergic lung disease
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010

Paediatric airway diseases
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019


LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

The German Severe Asthma Registry and Type 2-high and Type 2-low asthma phenotypes
Source: International Congress 2019 – Clinical aspects of airway diseases
Year: 2019

CT of the Airways
Source: Eur Respir Rev 2011; 20: 65
Year: 2011


Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
Source: Eur Respir J 2004; 24: 406-412
Year: 2004



The management of acute asthma in adults: the role of the Cochrane Airway Group (CAG) reviews
Source: Annual Congress 2012 - Cochrane reviews in airway diseases
Year: 2012


Prospective assessment of GOLD 2017 categories and COPD phenotypesCzech Multicentre Research Database of COPD Group
Source: International Congress 2017 – Notable abstracts in asthma
Year: 2017



Breakout Sessions II: chronic lung and heart disease
Source: ERS Summit on bridging the health divide in Europe 2012
Year: 2012

Epidemiology of non-communicable diseases: asthma and COPD
Source: Online Course 2014 - Respiratory epidemiology
Year: 2014


Association between Type 2 innate lymphoid cells increasement and allergy in patients with chronic rhinosinusitis and asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016


Asthma and allergic diseases in patients with Behçet‘s disease
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


Risk factors associated with severe COVID-19 in asthma. A report from the Swedish National Airway Register
Source: Virtual Congress 2021 – New evidence from longitudinal asthma cohorts and other key studies
Year: 2021